References
- Nandiraju D, Ahmed I. Human skeletal physiology and factors affecting its modelling and remodelling. Fertil Steril. 2019;112(5):775–781. doi: 10.1016/j.fertnstert.2019.10.005.
- Gómez-Alonso C. Paediatric metabolic bone disease: A lifetime ahead. Adv Ther. 2020;37(Suppl 2):38–46. doi: 10.1007/s12325-019-01174-3.
- Guss CE, McAllister A, Gordon CM. DXA in children and adolescents. J Clin Densitom. 2021;24(1):28–35. doi: 10.1016/j.jocd.2020.01.006.
- Ladang A, Rauch F, Delvin E, Cavalier E. Bone turnover markers in children: from laboratory challenges to clinical interpretation. Calcif Tissue Int. 2023;112(2):218–232. doi: 10.1007/s00223-022-00964-2.
- Hart NH, Newton RU, Tan J, Rantalainen T, Chivers P, Siafarikas A, et al. Biological basis of bone strength: anatomy, physiology and measurement. J Musculoskelet Neuronal Interact. 2020;20(3):347–371.
- Neve A, Corrado A, Cantatore FP. Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol. 2013;228:1149–1153. doi: 10.1002/jcp.24278.
- Golub EE, Boesze-Battaglia K. The role of alkaline phosphatase in mineralization. Curr Opin Orthop. 2007;18:444–448. doi: 10.1097/BCO.0b013e3282630851.
- Szulc P. Bone turnover: biology and assessment tools. Best Pract Res Clin Endocrinol Metab. 2018;32(5):725–738. doi: 10.1016/j.beem.2018.05.003.
- Hwang JS, Lee S, Gong HS. The impact of acute fracture on interpretation of bone turnover marker measurements for patients starting anti-resorptive therapies. Bone. 2022;154:116199. doi: 10.1016/j.bone.2021.116199.
- van Coeverden SC, Netelenbos JC, de Ridder CM, Roos JC, Popp-Snijders C, Delemarre-van de Waal HA. Bone metabolism markers and bone mass in healthy pubertal boys and girls. Clin Endocrinol (Oxf). 2002;57(1):107–16. doi: 10.1046/j.1365-2265.2002.01573.x.
- Ambroszkiewicz J, Gajewska J, Laskowska-Klita T. Serum osteocalcin and bone alkaline phosphatase in healthy children in relation to age and gender. Med Wieku Rozwoj. 2002;6(3):257–65.
- Gajewska J, Ambroszkiewicz J, Laskowska-Klita T. Osteoprotegerin and C-telopeptide of type I collagen in Polish healthy children and adolescents. Adv Med Sci. 2006;51:269–72.
- Geserick M, Vogel M, Eckelt F, Schlingmann M, Hiemisch A, Baber R, et al. Children and adolescents with obesity have reduced serum bone turnover markers and 25-hydroxyvitamin D but increased parathyroid hormone concentrations - results derived from new pediatric reference ranges. Bone. 2020;132:115124. doi: 10.1016/j.bone.2019.115124.
- Diemar SS, Lylloff L, Rønne MS, Møllehave LT, Heidemann M, Thuesen BH, et al. Reference intervals in Danish children and adolescents for bone turnover markers carboxy-terminal cross-linked telopeptide of type I collagen (β-CTX), pro-collagen type I N-terminal propeptide (PINP), osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP). Bone. 2021;146:115879. doi: 10.1016/j.bone.2021.115879.
- Kułaga Z, Różdżyńska-Świątkowska A, Grajda A, Gurzkowska B, Wojtyło M, Góźdź M, et al. Percentile charts for growth and nutritional status assessment in Polish children and adolescents from birth to 18 year of age. Stand. Med. 2015;12:119–135.
- Maggioli C, Stagi S. Bone modeling, remodeling, and skeletal health in children and adolescents: mineral accrual, assessment and treatment. Ann Pediatr Endocrinol Metab. 2017;22(1):1–5. doi: 10.6065/apem.2017.22.1.1.
- Cook SJ, Wall C. Paget’s disease of bone: A clinical update. Aust J Gen Pract. 2021;50(1–2):23–29. doi: 10.31128/AJGP-10-20-5690.
- Okten A, Cakir M, Makuloglu M. Bone mineral status, bone turnover markers and vitamin D status in children with congenital adrenal hyperplasia. Minerva Endocrinol. 2012;37(3):275–82.
- Karava V, Dotis J, Christoforidis A, Kondou A, Printza N. Muscle-bone axis in children with chronic kidney disease: current knowledge and future perspectives. Pediatr Nephrol. 2021;36(12):3813–3827. doi: 10.1007/s00467-021-04936-w.
- Guandalini S, Assiri A. Celiac disease: a review. JAMA Pediatr. 2014;168(3):272–278. doi: 10.1001/jamapediatrics.2013.3858.
- Wei H, Zhao Y, Xiang L. Bone health in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2023;17(9):921–935. doi: 10.1080/17474124.2023.2248874.
- Gajewska J, Ambroszkiewicz J, Laskowska-Klita T. Some bone turnover markers in serum of healthy children and adolescents in relation to age and gender. Wiad Lek. 2005;58(9–10):476–80.
- Wang X, Liu L, Li P, Ma J, Jiang R, Wang R, et al. Reference and influential factors of serum bone markers in Chinese adolescents. Sci Rep. 2017;7(1):17340. doi: 10.1038/s41598-017-17670-x.
- Paldánius PM, Ivaska KK, Mäkitie O, Viljakainen H. Serum and urinary osteocalcin in healthy 7- to 19-year-old Finnish children and adolescents. Front Pediatr. 2021;9:610227. doi: 10.3389/fped.2021.610227.
- Rand MS, Diemar SS, Møllehave LT, Heidemann M, Thuesen BH, Petersen JH, et al. Z-scores of bone turnover markers calculated from new established sex- and age-specific reference curves are associated to future change in BMD in children and adolescents. Bone. 2023;167:116641. doi: 10.1016/j.bone.2022.116641.
- Chubb SAP, Vasikaran SD, Gillett MJ. Reference intervals for plasma β-CTX and P1NP in children: A systematic review and pooled estimates. Clin Biochem. 2023;118:110582. doi: 10.1016/j.clinbiochem.2023.05.001.
- Federico G, Baroncelli GI, Vanacore T, Fiore L, Saggese G. Pubertal changes in biochemical markers of growth. Horm Res. 2003;60(Suppl1):46–51. doi: 10.1159/000071225.
- Diemar SS, Møllehave LT, Quardon N, Lylloff L, Thuesen BH, Linneberg A, et al. Effects of age and sex on osteocalcin and bone-specific alkaline phosphatase-reference intervals and confounders for two bone formation markers. Arch Osteoporos. 2020;15(1):26. doi: 10.1007/s11657-020-00715-6.
- Huang Y, Eapen E, Steele S, Grey V. Establishment of reference intervals for bone markers in children and adolescents. Clin Biochem. 2011;44(10–11):771–778. doi: 10.1016/j.clinbiochem.2011.04.008.
- Colantonio DA, Kyriakopoulou L, Chan MK, Daly CH, Brinc D, Venner AA, et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem. 2012;58(5):854–868. doi: 10.1373/clinchem.2011.177741.
- Fischer DC, Mischek A, Wolf S, Rahn A, Salweski B, Kundt G, et al. Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase. Ann Clin Biochem. 2012;49(Pt 6):546–553. doi: 10.1258/acb.2012.011274.
- Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, et al. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years. J Clin Endocrinol Metab. 2007;92(2):443–449. doi: 10.1210/jc.2006-1706.
- Bayer M. Reference values of osteocalcin and procollagen type I N-propeptide plasma levels in a healthy Central European population aged 0–18 years. Osteoporos Int. 2014;25(2):729–736. doi: 10.1007/s00198-013-2485-4.
- Herrmann D, Intemann T, Lauria F, Mårild S, Molnár D, Moreno LA, et al. Reference values of bone stiffness index and C-terminal telopeptide in healthy European children. Int J Obes (Lond). 2014;38(Suppl 2):S76–85. doi: 10.1038/ijo.2014.138.
- Crabtree NJ, Arabi A, Bachrach LK, Fewtrell M, El-Hajj Fuleihan G, et al. Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions. J Clin Densitom. 2014;17(2):225–242. doi: 10.1016/j.jocd.2014.01.003.
- Dimitri P, Wales JK, Bishop N. Fat and bone in children: differential effects of obesity on bone size and mass according to fracture history. J Bone Miner Res. 2010;25(3):527–536. doi: 10.1359/jbmr.090823.
- Vandewalle S, Taes Y, Van Helvoirt M, Debode P, Herregods N, Ernst C, et al. Bone size and bone strength are increased in obese male adolescents. J Clin Endocrinol Metab. 2013;98(7):3019–28. doi: 10.1210/jc.2012-3914.
- Nagasaki K, Kikuchi T, Hiura M, Uchiyama M. Obese Japanese children have low bone mineral density after puberty. J Bone Miner Metab. 2004;22(4):376–81. doi: 10.1007/s00774-004-0498-y.
- Gajewska J, Ambroszkiewicz J, Klemarczyk W, Chełchowska M, Weker H, Szamotulska K. The effect of weight loss on body composition, serum bone markers, and adipokines in prepubertal obese children after 1-year intervention. Endocr Res. 2018;43(2):80–89. doi: 10.1080/07435800.2017.1403444.
- Zürcher SJ, Borter N, Kränzlin M, Neyer P, Meyer U, Rizzoli R, et al. Relationship between bone mineral content and bone turnover markers, sex hormones and calciotropic hormones in pre- and early pubertal children. Osteoporos Int. 2020;31(2): 335–349. doi: 10.1007/s00198-019-05180-7.
- Monjardino T, Silva P, Amaro J, Carvalho O, Guimarães JT, Santos AC, et al. Bone formation and resorption markers at 7 years of age: Relations with growth and bone mineralization. PLoS One. 2019;14(8):e0219423. doi: 10.1371/journal.pone.0219423.
- Jürimäe J. Interpretation and application of bone turnover markers in children and adolescents. Curr Opin Pediatr. 2010;22(4):494–500. doi: 10.1097/MOP.0b013e32833b0b9e.
- Rosenquist C, Qvist P, Bjarnason N, Christiansen C. Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem. 1995;41(10):1439–45.
- Cavalier E, Delanaye P, Collette J, Krzesinski JM, Chapelle JP. Evaluation of different bone markers in hemodialyzed patients. Clin Chim Acta. 2006;371(1–2):107–11. doi: 10.1016/j.cca.2006.02.029.
- Diemar SS, Dahl SS, West AS, Simonsen SA, Iversen HK, Jørgensen NR. A systematic review of the circadian rhythm of bone markers in blood. Calcif Tissue Int. 2023; 112(2):126–147. doi: 10.1007/s00223-022-00965-1.
- Oladipo OO, DeCrescenzo AJ, Marquez CP, Okorodudu AO. Increased alkaline phosphatase in a child. Clin Chem. 2017;63(6):1174–1175. doi: 10.1373/clinchem.2016.268904.
- Bianchi ML, Leonard MB, Bechtold S, Högler W, Mughal MZ, Schönau E, et al. Bone health in children and adolescents with chronic diseases that may affect the skeleton: the 2013 ISCD Pediatric Official Positions. J Clin Densitom. 2014;17(2):281–94. doi: 10.1016/j.jocd.2014.01.005.
- Höppner J, Steff K, Misof BM, Schündeln MM, Hövel M, Lücke T, et al. Clinical course in two children with Juvenile Paget’s disease during long-term treatment with intravenous bisphosphonates. Bone Rep. 2021;14:100762. doi: 10.1016/j.bonr.2021.100762.
- Arundel P, Borg SA. Early life management of osteogenesis mperfecta. Curr Osteoporos Rep. 2023;21(6):779–786. doi: 10.1007/s11914-023-00823-5.
- Weber DR. Bone health in childhood chronic disease. Endocrinol Metab Clin North Am. 2020;49(4):637–650. doi: 10.1016/j.ecl.2020.07.002.